Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Valerie Gruber, PhD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentPsychiatry
    Address1001 Potrero Ave, SFGH 90
    San Francisco CA 94143
    Phone415-206-3943

       Biography 
       Education and Training
      Kent State UniversityPh.D.Clinical Psychology1990
      UC BerkeleyM.P.H.School of Public Health1992
       Awards and Honors
      UCSF Clinical Psychology Training Program2014David Rea Training Award

       Overview 
       Overview
      VALERIE A. GRUBER is Professor in the Department of Psychiatry at UCSF, and faculty in the Public Service and Minorities Track of the UCSF Clinical Psychology Training Program. Dr. Gruber is a licensed psychologist, and holds an APA certificate in the treatment of alcohol and other substance use disorders. She completed a Ph.D. in Clinical Psychology at Kent State University, internship at the UCSF Clinical Psychology Training Program, and an M.P.H. at the University of California Berkeley. Her work as a clinician and educator has focused on developing culturally competent, trauma-informed substance abuse and mental health services for low-income substance users with chronic medical conditions such as HIV. Dr. Gruber's program of research aims to improve substance abuse treatment and medical care for substance users from sexual and ethnic minority communities. She has published research on psychosocial interventions in methadone maintenance and outpatient addiction treatment. She is a senior clinical consultant with the San Francisco Treatment Research Center, and coinvestigator in a study of web-based and group interventions for smoking cessation in residential addiction treatment.

       Interests
      My clinical, teaching and research efforts focus on improving addiction treatment for culturally diverse, low-income substance users, including individuals living with HIV. Areas of expertise include trauma-informed integrated treatment of substance use and psychiatric disorders, with persons of color and LGBTIQ individuals, in addiction treatment, mental health, and primary care settings. Skills include motivational interviewing, individual, couples and group psychotherapy, psychological assessment, cultural competence, staff development, program management, and clinical research. My research has focused on improving treatment of substance use disorders and associated medical conditions in disenfranchised populations.

       ORNG Applications 
       Featured Publications
       Websites
       In The News
       Faculty Mentoring
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Carrico AW, Flentje A, Gruber VA, Woods WJ, Discepola MV, Dilworth SE, Neilands TB, Jain J, Siever MD. Community-based harm reduction substance abuse treatment with methamphetamine-using men who have sex with men. J Urban Health. 2014 Jun; 91(3):555-67.
        View in: PubMed
      2. McCance-Katz EF, Gruber VA, Beatty G, Lum P, Ma Q, DiFrancesco R, Hochreiter J, Wallace PK, Faiman MD, Morse GD. Interaction of disulfiram with antiretroviral medications: Efavirenz increases while atazanavir decreases disulfiram effect on enzymes of alcohol metabolism. Am J Addict. 2014 Mar; 23(2):137-44.
        View in: PubMed
      3. Gruber VA, Rainey PM, Lum PJ, Beatty GW, Aweeka FT, McCance-Katz EF. Interactions between Alcohol and the HIV Entry Inhibitor Maraviroc. J Int Assoc Provid AIDS Care. 2013 Nov-Dec; 12(6):375-7.
        View in: PubMed
      4. McCance-Katz EF, Gruber VA, Beatty G, Lum PJ, Rainey PM. Interactions between alcohol and the antiretroviral medications ritonavir or efavirenz. J Addict Med. 2013 Jul-Aug; 7(4):264-70.
        View in: PubMed
      5. Sorensen JL, Haug NA, Larios S, Gruber VA, Tulsky J, Powelson E, Logan DP, Shapiro B. Directly administered antiretroviral therapy: pilot study of a structural intervention in methadone maintenance. J Subst Abuse Treat. 2012 Dec; 43(4):418-23.
        View in: PubMed
      6. McCance-Katz EF, Lum PJ, Beatty G, Gruber VA, Peters M, Rainey PM. Untreated HIV infection is associated with higher blood alcohol levels. J Acquir Immune Defic Syndr. 2012 Jul 1; 60(3):282-8.
        View in: PubMed
      7. Gruber VA, Rainey PM, Moody DE, Morse GD, Ma Q, Prathikanti S, Pade PA, Alvanzo AA, McCance-Katz EF. Interactions between buprenorphine and the protease inhibitors darunavir-ritonavir and fosamprenavir-ritonavir. Clin Infect Dis. 2012 Feb 1; 54(3):414-23.
        View in: PubMed
      8. Gruber VA, McCance-Katz EF. Methadone, buprenorphine, and street drug interactions with antiretroviral medications. Curr HIV/AIDS Rep. 2010 Aug; 7(3):152-60.
        View in: PubMed
      9. Kahn R, Biswas K, Childress AR, Shoptaw S, Fudala PJ, Gorgon L, Montoya I, Collins J, McSherry F, Li SH, Chiang N, Alathari H, Watson D, Liberto J, Beresford T, Stock C, Wallace C, Gruber V, Elkashef A. Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals. Drug Alcohol Depend. 2009 Jul 1; 103(1-2):59-64.
        View in: PubMed
      10. Gruber VA, Delucchi KL, Kielstein A, Batki SL. A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification. Drug Alcohol Depend. 2008 Apr 1; 94(1-3):199-206.
        View in: PubMed
      11. Haug NA, Shopshire M, Tajima B, Gruber V, Guydish J. Adoption of evidence-based practices among substance abuse treatment providers. J Drug Educ. 2008; 38(2):181-92.
        View in: PubMed
      12. Haug NA, Sorensen JL, Gruber VA, Lollo N, Roth G. HAART adherence strategies for methadone clients who are HIV-positive: a treatment manual for implementing contingency management and medication coaching. Behav Modif. 2006 Nov; 30(6):752-81.
        View in: PubMed
      13. Sorensen JL, Haug NA, Delucchi KL, Gruber V, Kletter E, Batki SL, Tulsky JP, Barnett P, Hall S. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend. 2007 Apr 17; 88(1):54-63.
        View in: PubMed
      14. Haug NA, Sorensen JL, Lollo ND, Gruber VA, Delucchi KL, Hall SM. Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial. AIDS Care. 2005 Nov; 17(8):1022-9.
        View in: PubMed
      15. Batki SL, Gruber VA, Bradley JM, Bradley M, Delucchi K. A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users. Drug Alcohol Depend. 2002 May 1; 66(3):283-93.
        View in: PubMed
      16. Moos RH, Pettit B, Gruber V. Longer episodes of community residential care reduce substance abuse patients' readmission rates. J Stud Alcohol. 1995 Jul; 56(4):433-43.
        View in: PubMed
      17. Moos RH, Pettit B, Gruber VA. Characteristics and outcomes of three models of community residential care for abuse patients. J Subst Abuse. 1995; 7(1):99-116.
        View in: PubMed
      18. Allen S, Serufilira A, Gruber V, Kegeles S, Van de Perre P, Carael M, Coates TJ. Pregnancy and contraception use among urban Rwandan women after HIV testing and counseling. Am J Public Health. 1993 May; 83(5):705-10.
        View in: PubMed
      Valerie's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP